We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ASMB market cap is 70.68M. The company's latest EPS is USD -9.6327 and P/E is -1.17.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 7.16M | 5.79M | 8.53M | 6.85M |
| Operating Income | -15.05M | -12.55M | -10.73M | -12.2M | -10.96M |
| Net Income | -14.42M | -10.96M | -9.08M | -11.15M | -9.61M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 15.96M | 79.11M | 6.25M | 0 | 7.16M |
| Operating Income | -102.71M | -64.08M | -132.69M | -94.11M | -64.65M |
| Net Income | -97.63M | -62.15M | -129.86M | -93.09M | -61.23M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 51.63M | 136.82M | 119.88M | 115.32M | 100.26M |
| Total Liabilities | 9.92M | 95.73M | 87.28M | 80.64M | 74.26M |
| Total Equity | 41.71M | 41.1M | 32.6M | 34.68M | 26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 339.91M | 283.25M | 191.06M | 101.79M | 136.82M |
| Total Liabilities | 66.69M | 42.68M | 22.13M | 19.13M | 95.73M |
| Total Equity | 273.22M | 240.58M | 168.93M | 82.66M | 41.1M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -50.9M | 22.74M | -18.36M | -35.47M | -50.71M |
| Investing | 20.52M | -69.14M | 17.27M | 22.38M | 46.87M |
| Financing | 4.63M | 13.82M | N/A | 12.45M | 12.45M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -84.07M | -62.96M | -93.4M | -84.46M | 22.74M |
| Investing | -50.32M | 68.07M | 26.52M | 90.64M | -69.14M |
| Financing | 139.65M | 7.6M | 53.06M | 614k | 13.82M |
| Market Cap | 70.68M |
| Price to Earnings Ratio | -1.17 |
| Price to Sales Ratio | 10 |
| Price to Cash Ratio | 3.61 |
| Price to Book Ratio | 1.74 |
| Dividend Yield | - |
| Shares Outstanding | 6.36M |
| Average Volume (1 week) | 23.63k |
| Average Volume (1 Month) | 27.81k |
| 52 Week Change | -15.89% |
| 52 Week High | 19.93 |
| 52 Week Low | 11.23 |
| Spread (Intraday) | 2.77 (20.55%) |
| Company Name | Assembly Biosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.assemblybio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
